Lopressor injection/adult indications and dosage

Jump to navigation Jump to search
Lopressor injection/adult indications and dosage®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration and Monitoring
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

FDA-Labeled Indications and Dosage (Adult)

Myocardial Infarction

  • If unable to tolerate the full IV dose: Lopressor tablet 25—50 mg PO q6h for 2 days

Lopressor injection is indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used in conjunction with oral Lopressor maintenance therapy. Treatment with Lopressor injection can be initiated as soon as the patient’s clinical condition allows.

Off-Label Use and Dosage (Adult)

Cardiac dysrhythmia

Lopressor injection (range: 2—15 mg) has been shown to be effective in the treatment of atrial flutter, atrial fibrillation, multifocal atrial tachycardia, and supraventricular tachycardia.[1]

Congestive heart failure

Glaucoma

Injection site pain - Propofol adverse reaction

Ischemic heart disease, acute; Prophylaxis

Migraine; Prophylaxis

Tremor

References

  1. Amsterdam, EA.; Kulcyski, J.; Ridgeway, MG. (1991). "Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias". J Clin Pharmacol. 31 (8): 714–8. PMID 1880230. Unknown parameter |month= ignored (help)